Impact BioMedical, Inc. (IBO) Stock Statistics & Valuation Metrics

Impact BioMedical, Inc. has a market cap or net worth of $61.61M. The enterprise value is $7.19M.

Impact BioMedical, Inc. has 107,821,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

Impact BioMedical, Inc.’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -21.59%.

The current PE Ratio of Impact BioMedical, Inc. is ―. Impact BioMedical, Inc.’s PEG ratio is -0.00025.

In the last 12 months, Impact BioMedical, Inc. had revenue of 32.00K and earned -11.84M in profits. Earnings per share was -0.38.

In the last 12 months, operating cash flow was -508.00K and capital expenditures 0.00, giving a free cash flow of -508.00K billion.

Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Impact BioMedical, Inc. upcoming earnings date is ―, ―.

Impact BioMedical, Inc. as a current ratio of 0.35, with Debt / Equity ratio of 0.00%

In the past 12 months, Impact BioMedical, Inc. has paid -2.58M in taxes.

Impact BioMedical, Inc. EV to EBITDA ratio is -1.27, with an EV/FCF ratio of -8.43.

Impact BioMedical, Inc. has $10.00K in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.00K billion.

Gross margin is -1111.43%, with operating margin of -13343.75%, and net profit margin of -36993.75%.

The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―